Hepatitis B cell-free DNA in non-invasive prenatal testing as an early biomarker of viral infectivity
Non-invasive prenatal testing (NIPT) was initially developed to detect chromosomal abnormalities in fetuses through the analysis of cell-free fetal DNA in maternal blood. Recent advancements have expanded NIPT's applications to include the detection of viral infections during pregnancy. However, interpreting pathogen-d...